Zenio Rondowsky
Corneal and Contact Management · Dunwoody, GANPI 1750342150
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 24.8% of the total. That places this record below the midpoint for corneal and contact management clinicians in GA, where the typical reported total is $1,165.
Across 14 payments — averaging $31.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$111
- ABB Con-cise Optical Group LLC$69
- Mallinckrodt Hospital Products Inc.$52
- Johnson & Johnson Vision Care, Inc.$43
- Bausch & Lomb, A Division Of Bausch Health US, LLC$43
- Tarsus Pharmaceuticals, Inc.$28
- plus $101 from 5 others
What the payments were for
- Food & beverage$447100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$447 in reported general payments places this provider in the 25th percentile of 34 corneal and contact management providers in Georgia.
See all corneal and contact management providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 11 | $7,795 |
| Prednisolone Acetate | 28 | $936 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 50 | $377 |
| Latanoprost | 27 | $74 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Dunwoody
- Sima DoriDunwoody$127
- Sally DillehaySandy Springs$275K
- Mastoureh AhmadpourDouglasville$30K
- Rohit SharmaAtlanta$22K
- Robert BarnesAtlanta$7K
- Kenneth JonesAtlanta$5K
- Karen CastleberryAthens$4K
- Nhat Anh HoPeachtree Corners$3K
- Adekunle OluwadareDacula$3K
- Farhad KapadiaLithonia$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.